Metraipolis › archive › dc_3eff830ed58c

CD14- CD16+ monocyte PD-L1 prevents early tuberculosis progression and constrains reactivation under immune checkpoint therapy — Europe PMC PMID:41446278

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41446278
DOI
10.3389/fcimb.2025.1684030
License (as archived)
solo-consultazione
Archived
2026-11-07T19:12:43.672Z
SHA-256 of the archived text
504c0011e2a63d71028fbf54631cf504b14a14f3442cba9c9ec6968f66ab2386
Stable URL of this page
https://metraipolis.com/documento/dc_3eff830ed58c

How to cite

CD14- CD16+ monocyte PD-L1 prevents early tuberculosis progression and constrains reactivation under immune checkpoint therapy — Europe PMC PMID:41446278 — Europe PMC (en), https://europepmc.org/article/MED/41446278 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_3eff830ed58c (Metraipolis archive dc_3eff830ed58c, sha256 504c0011e2a63d71028fbf54631cf504b14a14f3442cba9c9ec6968f66ab2386)
BibTeX
@misc{dc3eff830ed58c,
  title = {CD14- CD16+ monocyte PD-L1 prevents early tuberculosis progression and constrains reactivation under immune checkpoint therapy — Europe PMC PMID:41446278},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41446278},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_3eff830ed58c; sha256 504c0011e2a63d71028fbf54631cf504b14a14f3442cba9c9ec6968f66ab2386},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41446278. Agents can read the archived copy with the MCP tool read_document.